Terms: = Ovarian cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12
142 results:
1. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
Mikhael S; Kurdi A; Khoueiry-Zgheib N; Tahtouh R; Nasr R; Hilal G
PLoS One; 2024; 19(3):e0298127. PubMed ID: 38489280
[TBL] [Abstract] [Full Text] [Related]
2. Air quality and cancer risk in the All of Us Research Program.
Craver A; Luo J; Kibriya MG; Randorf N; Bahl K; Connellan E; Powell J; Zakin P; Jones RR; Argos M; Ho J; Kim K; Daviglus ML; Greenland P; Ahsan H; Aschebrook-Kilfoy B
Cancer Causes Control; 2024 May; 35(5):749-760. PubMed ID: 38145439
[TBL] [Abstract] [Full Text] [Related]
3. Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer.
Zebic DS; Tjokrowidjaja A; Francis KE; Friedlander M; Gebski V; Lortholary A; Joly F; Hasenburg A; Mirza M; Denison U; Cecere SC; Ferrero A; Pujade-Lauraine E; Lee CK
Br J Cancer; 2024 Feb; 130(3):425-433. PubMed ID: 38097739
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas.
Jamieson A; Vermij L; Kramer CJH; Jobsen JJ; Jürgemlienk-Schulz I; Lutgens L; Mens JW; Haverkort MAD; Slot A; Nout RA; Oosting J; Carlson J; Howitt BE; Ip PPC; Lax SF; McCluggage WG; Singh N; McAlpine JN; Creutzberg CL; Horeweg N; Gilks CB; Bosse T
Clin Cancer Res; 2023 Dec; 29(23):4949-4957. PubMed ID: 37773079
[TBL] [Abstract] [Full Text] [Related]
5. Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey.
Kim JH; Lee Y; Kim DY; Kim S; Seo SS; Kang S; Park SY; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e3. PubMed ID: 37681357
[TBL] [Abstract] [Full Text] [Related]
6. Mortality Benefit of a Blood-Based Biomarker Panel for Lung cancer on the Basis of the Prostate, Lung, Colorectal, and ovarian Cohort.
Irajizad E; Fahrmann JF; Marsh T; Vykoukal J; Dennison JB; Long JP; Do KA; Feng Z; Hanash S; Ostrin EJ
J Clin Oncol; 2023 Sep; 41(27):4360-4368. PubMed ID: 37379494
[TBL] [Abstract] [Full Text] [Related]
7. A combined clinical and genetic model for predicting risk of ovarian cancer.
Dite GS; Spaeth E; Murphy NM; Allman R
Eur J Cancer Prev; 2023 Jan; 32(1):57-64. PubMed ID: 36503897
[TBL] [Abstract] [Full Text] [Related]
8. Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung cancer Cells).
Nahar J; Boopathi V; Murugesan M; Rupa EJ; Yang DC; Kang SC; Mathiyalagan R
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500403
[TBL] [Abstract] [Full Text] [Related]
9. A review on the role of PCGEM1 lncRNA in cancer.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
Pathol Res Pract; 2022 Dec; 240():154223. PubMed ID: 36403313
[TBL] [Abstract] [Full Text] [Related]
10. Novel approach of desensitization in allergic reaction to Olaparib.
Beurer BM; Sprenger LM; Graneß K; Feldmann F; Warnke U; Biersack MG; Fischer D
J Oncol Pharm Pract; 2023 Jun; 29(4):967-970. PubMed ID: 36128835
[TBL] [Abstract] [Full Text] [Related]
11. Ultra-processed food consumption and the risk of pancreatic cancer in the Prostate, Lung, Colorectal and ovarian cancer Screening Trial.
Zhong GC; Zhu Q; Cai D; Hu JJ; Dai X; Gong JP; Sun WP
Int J Cancer; 2023 Mar; 152(5):835-844. PubMed ID: 36094042
[TBL] [Abstract] [Full Text] [Related]
12. Human epididymis protein 4 (HE4) is a novel immunohistochemical marker of neuroendocrine differentiation.
Su W; Yang K; Jiang H; Song H; Feng K; Li Q
Virchows Arch; 2022 Sep; 481(3):433-441. PubMed ID: 35913578
[TBL] [Abstract] [Full Text] [Related]
13. pH-Sensing G Protein-Coupled Receptor OGR1 (GPR68) Expression and Activation Increases in Intestinal Inflammation and Fibrosis.
de Vallière C; Cosin-Roger J; Baebler K; Schoepflin A; Mamie C; Mollet M; Schuler C; Bengs S; Lang S; Scharl M; Seuwen K; Ruiz PA; Hausmann M; Rogler G
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163345
[TBL] [Abstract] [Full Text] [Related]
14. The Correlation between YAP and rhoa Expression in Prostate and ovarian Tumor Stroma.
Lee MJ; Kim D
Asian Pac J Cancer Prev; 2022 Jan; 23(1):281-285. PubMed ID: 35092398
[TBL] [Abstract] [Full Text] [Related]
15. Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast cancer Susceptibility Genes.
; Mavaddat N; Dorling L; Carvalho S; Allen J; González-Neira A; Keeman R; Bolla MK; Dennis J; Wang Q; Ahearn TU; Andrulis IL; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Blomqvist C; Bogdanova NV; Bojesen SE; Briceno I; Brüning T; Camp NJ; Campbell A; Castelao JE; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Christiansen H; Czene K; Dörk T; Eriksson M; Evans DG; Fasching PA; Figueroa JD; Flyger H; Gabrielson M; Gago-Dominguez M; Geisler J; Giles GG; Guénel P; Hadjisavvas A; Hahnen E; Hall P; Hamann U; Hartikainen JM; Hartman M; Hoppe R; Howell A; Jakubowska A; Jung A; Khusnutdinova EK; Kristensen VN; Li J; Lim SH; Lindblom A; Loizidou MA; Lophatananon A; Lubinski J; Madsen MJ; Mannermaa A; Manoochehri M; Margolin S; Mavroudis D; Milne RL; Mohd Taib NA; Morra A; Muir K; Obi N; Osorio A; Park-Simon TW; Peterlongo P; Radice P; Saloustros E; Sawyer EJ; Schmutzler RK; Shah M; Sim X; Southey MC; Thorne H; Tomlinson I; Torres D; Truong T; Yip CH; Spurdle AB; Vreeswijk MPG; Dunning AM; García-Closas M; Pharoah PDP; Kvist A; Muranen TA; Nevanlinna H; Teo SH; Devilee P; Schmidt MK; Easton DF
JAMA Oncol; 2022 Mar; 8(3):e216744. PubMed ID: 35084436
[TBL] [Abstract] [Full Text] [Related]
16. FPR2 participates in epithelial ovarian cancer (EOC) progression through rhoa-mediated M2 macrophage polarization.
Xie X; He J; Wang Q; Liu Y; Chen W; Shi K
J Ovarian Res; 2021 Dec; 14(1):177. PubMed ID: 34930387
[TBL] [Abstract] [Full Text] [Related]
17. TAGLN mediated stiffness-regulated ovarian cancer progression via rhoa/ROCK pathway.
Wei X; Lou H; Zhou D; Jia Y; Li H; Huang Q; Ma J; Yang Z; Sun C; Meng Y; Xu S; Yang X; Li X; Ji T; Guo Z; Gao Q
J Exp Clin Cancer Res; 2021 Sep; 40(1):292. PubMed ID: 34538264
[TBL] [Abstract] [Full Text] [Related]
18. Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced ovarian cancer: A Clinical Study of 100 Patients.
Zhang J; Li XB; Ji ZH; Ma R; Bai WP; Li Y
Biomed Res Int; 2021; 2021():5533134. PubMed ID: 34258265
[TBL] [Abstract] [Full Text] [Related]
19. Ezrin Promotes the Proliferation, Migration, and Invasion of ovarian cancer Cells.
Li MJ; Xiong D; Huang H; Wen ZY
Biomed Environ Sci; 2021 Feb; 34(2):139-151. PubMed ID: 33685573
[TBL] [Abstract] [Full Text] [Related]
20. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of rhoa.
El-Mais N; Fakhoury I; Abdellatef S; Abi-Habib R; El-Sibai M
J Ovarian Res; 2021 Jan; 14(1):13. PubMed ID: 33423701
[TBL] [Abstract] [Full Text] [Related]
[Next]
